Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.

Ma L, Shen F, Jun K, Bao C, Kuo R, Young WL, Nishimura SL, Su H.

Transl Stroke Res. 2016 Dec;7(6):488-496. Epub 2016 Jun 29.

2.

Morphometric characterization of brain arteriovenous malformations for clinical and radiological studies to identify silent intralesional microhemorrhages.

Pekmezci M, Nelson J, Su H, Hess C, Lawton MT, Sonmez M, Young WL, Kim H, Tihan T.

Clin Neuropathol. 2016 May-Jun;35(3):114-21. doi: 10.5414/NP300937.

3.

Correction: Activation of α-7 Nicotinic Acetylcholine Receptor Reduces Ischemic Stroke Injury through Reduction of Pro-Inflammatory Macrophages and Oxidative Stress.

Han Z, Shen F, He Y, Degos V, Camus M, Maze M, Young WL, Su H.

PLoS One. 2016 Mar 17;11(3):e0152218. doi: 10.1371/journal.pone.0152218. eCollection 2016. No abstract available.

4.

Genome-wide association study of sporadic brain arteriovenous malformations.

Weinsheimer S, Bendjilali N, Nelson J, Guo DE, Zaroff JG, Sidney S, McCulloch CE, Al-Shahi Salman R, Berg JN, Koeleman BP, Simon M, Bostroem A, Fontanella M, Sturiale CL, Pola R, Puca A, Lawton MT, Young WL, Pawlikowska L, Klijn CJ, Kim H; GEN-AVM Consortium.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):916-23. doi: 10.1136/jnnp-2015-312272. Epub 2016 Jan 27.

5.

Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.

Kim H, Nelson J, Krings T, terBrugge KG, McCulloch CE, Lawton MT, Young WL, Faughnan ME; Brain Vascular Malformation Consortium HHT Investigator Group.

Stroke. 2015 May;46(5):1362-4. doi: 10.1161/STROKEAHA.114.007367. Epub 2015 Apr 9.

6.

The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.

Pawlikowska L, Nelson J, Guo DE, McCulloch CE, Lawton MT, Young WL, Kim H, Faughnan ME; Brain Vascular Malformation Consortium HHT Investigator Group.

Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2.

7.

Current surgical results with low-grade brain arteriovenous malformations.

Potts MB, Lau D, Abla AA, Kim H, Young WL, Lawton MT; UCSF Brain AVM Study Project.

J Neurosurg. 2015 Apr;122(4):912-20. doi: 10.3171/2014.12.JNS14938. Epub 2015 Feb 6.

8.

Adult mouse venous hypertension model: common carotid artery to external jugular vein anastomosis.

Yang ST, Rodriguez-Hernandez A, Walker EJ, Young WL, Su H, Lawton MT.

J Vis Exp. 2015 Jan 27;(95):50472. doi: 10.3791/50472.

9.

Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations.

Krings T, Kim H, Power S, Nelson J, Faughnan ME, Young WL, terBrugge KG; Brain Vascular Malformation Consortium HHT Investigator Group.

AJNR Am J Neuroradiol. 2015 May;36(5):863-70. doi: 10.3174/ajnr.A4210. Epub 2015 Jan 8.

10.

Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation.

Guo Y, Tihan T, Kim H, Hess C, Lawton MT, Young WL, Zhao Y, Su H.

Neuroimmunol Neuroinflamm. 2014;1(3):147-152.

11.

The natural history of AVM hemorrhage in the posterior fossa: comparison of hematoma volumes and neurological outcomes in patients with ruptured infra- and supratentorial AVMs.

Abla AA, Nelson J, Rutledge WC, Young WL, Kim H, Lawton MT.

Neurosurg Focus. 2014 Sep;37(3):E6. doi: 10.3171/2014.7.FOCUS14211.

12.

Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress.

Han Z, Shen F, He Y, Degos V, Camus M, Maze M, Young WL, Su H.

PLoS One. 2014 Aug 26;9(8):e105711. doi: 10.1371/journal.pone.0105711. eCollection 2014. Erratum in: PLoS One. 2016;11(3):e0152218.

13.

Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.

Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL; MARS Coinvestigators.

Neurology. 2014 Aug 12;83(7):590-7. doi: 10.1212/WNL.0000000000000688. Epub 2014 Jul 11.

14.

Endoglin deficiency impairs stroke recovery.

Shen F, Degos V, Chu PL, Han Z, Westbroek EM, Choi EJ, Marchuk D, Kim H, Lawton MT, Maze M, Young WL, Su H.

Stroke. 2014 Jul;45(7):2101-6. doi: 10.1161/STROKEAHA.114.005115. Epub 2014 May 29.

15.

Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms.

Bendjilali N, Nelson J, Weinsheimer S, Sidney S, Zaroff JG, Hetts SW, Segal M, Pawlikowska L, McCulloch CE, Young WL, Kim H.

J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1280-3. doi: 10.1136/jnnp-2013-306461. Epub 2014 Apr 28.

16.

Stereotactic radiosurgery at a low marginal dose for the treatment of pediatric arteriovenous malformations: obliteration, complications, and functional outcomes.

Potts MB, Sheth SA, Louie J, Smyth MD, Sneed PK, McDermott MW, Lawton MT, Young WL, Hetts SW, Fullerton HJ, Gupta N.

J Neurosurg Pediatr. 2014 Jul;14(1):1-11. doi: 10.3171/2014.3.PEDS13381. Epub 2014 Apr 25.

17.

Deep arteriovenous malformations in the basal ganglia, thalamus, and insula: multimodality management, patient selection, and results.

Potts MB, Jahangiri A, Jen M, Sneed PK, McDermott MW, Gupta N, Hetts SW, Young WL, Lawton MT; UCSF Brain AVM Study Project.

World Neurosurg. 2014 Sep-Oct;82(3-4):386-94. doi: 10.1016/j.wneu.2014.03.033. Epub 2014 Mar 19.

18.

Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.

Choi EJ, Chen W, Jun K, Arthur HM, Young WL, Su H.

PLoS One. 2014 Feb 10;9(2):e88511. doi: 10.1371/journal.pone.0088511. eCollection 2014.

19.

Induction of brain arteriovenous malformation in the adult mouse.

Chen W, Young WL, Su H.

Methods Mol Biol. 2014;1135:309-16. doi: 10.1007/978-1-4939-0320-7_25. Erratum in: Methods Mol Biol. 2014;1135:E1.

20.

De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation.

Chen W, Sun Z, Han Z, Jun K, Camus M, Wankhede M, Mao L, Arnold T, Young WL, Su H.

Stroke. 2014 Mar;45(3):900-2. doi: 10.1161/STROKEAHA.113.003655. Epub 2014 Jan 23.

21.

Endovascular biopsy: evaluating the feasibility of harvesting endothelial cells using detachable coils.

Cooke DL, Su H, Sun Z, Guo Y, Guo D, Saeed MM, Hetts SW, Higashida RT, Dowd CF, Young WL, Halbach VV.

Interv Neuroradiol. 2013 Dec;19(4):399-408. Epub 2013 Dec 18.

22.

MRI blood-brain barrier permeability measurements to predict hemorrhagic transformation in a rat model of ischemic stroke.

Hoffmann A, Bredno J, Wendland MF, Derugin N, Hom J, Schuster T, Zimmer C, Su H, Ohara PT, Young WL, Wintermark M.

Transl Stroke Res. 2012 Dec;3(4):508-16. doi: 10.1007/s12975-012-0212-7. Epub 2012 Sep 16.

PMID:
24323835
23.

Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ; international ARUBA investigators.

Lancet. 2014 Feb 15;383(9917):614-21. doi: 10.1016/S0140-6736(13)62302-8. Epub 2013 Nov 20.

24.

A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformation.

Bendjilali N, Kim H, Weinsheimer S, Guo DE, Kwok PY, Zaroff JG, Sidney S, Lawton MT, McCulloch CE, Koeleman BP, Klijn CJ, Young WL, Pawlikowska L.

PLoS One. 2013 Oct 3;8(10):e71434. doi: 10.1371/journal.pone.0071434. eCollection 2013.

25.

Angiographic features help predict outcome after stereotactic radiosurgery for the treatment of pediatric arteriovenous malformations.

Sheth SA, Potts MB, Sneed PK, Young WL, Cooke DL, Gupta N, Hetts SW.

Childs Nerv Syst. 2014 Feb;30(2):241-7. doi: 10.1007/s00381-013-2231-4. Epub 2013 Jul 27.

26.

Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes.

Gabarrós Canals A, Rodríguez-Hernández A, Young WL, Lawton MT; UCSF Brain AVM Study Project.

J Neurosurg. 2013 Sep;119(3):616-28. doi: 10.3171/2013.6.JNS122333. Epub 2013 Jul 12.

27.

Deep arteriovenous malformations in the Basal Ganglia, thalamus, and insula: microsurgical management, techniques, and results.

Potts MB, Young WL, Lawton MT; UCSF Brain AVM Study Project.

Neurosurgery. 2013 Sep;73(3):417-29. doi: 10.1227/NEU.0000000000000004.

28.

Perioperative management of coagulation in nontraumatic intracerebral hemorrhage.

Degos V, Westbroek EM, Lawton MT, Hemphill JC 3rd, Del Zoppo GJ, Young WL.

Anesthesiology. 2013 Jul;119(1):218-27. doi: 10.1097/ALN.0b013e318297c18a. Review. No abstract available.

29.

Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.

Akers AL, Ball KL, Clancy M, Comi AM, Faughnan ME, Gopal-Srivastava R, Jacobs TP, Kim H, Krischer J, Marchuk DA, McCulloch CE, Morrison L, Moses M, Moy CS, Pawlikowska L, Young WL.

J Rare Disord. 2013 Apr 1;1(1):5.

30.

Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results.

Hasan DM, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta VA, Young WL, Hashimoto T, Richard Winn H, Heistad D.

J Am Heart Assoc. 2013 Feb 22;2(1):e000019. doi: 10.1161/JAHA.112.000019.

31.

Bone fracture exacerbates murine ischemic cerebral injury.

Degos V, Maze M, Vacas S, Hirsch J, Guo Y, Shen F, Jun K, van Rooijen N, Gressens P, Young WL, Su H.

Anesthesiology. 2013 Jun;118(6):1362-72. doi: 10.1097/ALN.0b013e31828c23f8.

32.

Imaging aspirin effect on macrophages in the wall of human cerebral aneurysms using ferumoxytol-enhanced MRI: preliminary results.

Hasan DM, Chalouhi N, Jabbour P, Magnotta VA, Kung DK, Young WL.

J Neuroradiol. 2013 Jul;40(3):187-91. doi: 10.1016/j.neurad.2012.09.002. Epub 2013 Feb 18.

PMID:
23428244
33.

Depletion of bone marrow-derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction.

Degos V, Vacas S, Han Z, van Rooijen N, Gressens P, Su H, Young WL, Maze M.

Anesthesiology. 2013 Mar;118(3):527-36. doi: 10.1097/ALN.0b013e3182834d94.

34.

G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation.

Weinsheimer S, Brettman AD, Pawlikowska L, Wu DC, Mancuso MR, Kuhnert F, Lawton MT, Sidney S, Zaroff JG, McCulloch CE, Young WL, Kuo C, Kim H.

Transl Stroke Res. 2012 Dec;3(4):418-27. doi: 10.1007/s12975-012-0202-9. Epub 2012 Aug 14.

35.

Endoglin deficiency in bone marrow is sufficient to cause cerebrovascular dysplasia in the adult mouse after vascular endothelial growth factor stimulation.

Choi EJ, Walker EJ, Degos V, Jun K, Kuo R, Pile-Spellman J, Su H, Young WL.

Stroke. 2013 Mar;44(3):795-8. doi: 10.1161/STROKEAHA.112.671974. Epub 2013 Jan 10.

36.

Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci.

Shen F, Kuo R, Milon-Camus M, Han Z, Jiang L, Young WL, Su H.

Stroke. 2013 Jan;44(1):252-4. doi: 10.1161/STROKEAHA.112.662965. Epub 2012 Dec 18.

37.

Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

Chen W, Guo Y, Walker EJ, Shen F, Jun K, Oh SP, Degos V, Lawton MT, Tihan T, Davalos D, Akassoglou K, Nelson J, Pile-Spellman J, Su H, Young WL.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):305-10. doi: 10.1161/ATVBAHA.112.300485. Epub 2012 Dec 13.

38.

Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study.

Hasan D, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta VA, Young WL, Hashimoto T, Winn HR, Heistad D.

Stroke. 2012 Dec;43(12):3258-65. doi: 10.1161/STROKEAHA.112.673400. Epub 2012 Nov 8.

39.

Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation.

Hasan DM, Amans M, Tihan T, Hess C, Guo Y, Cha S, Su H, Martin AJ, Lawton MT, Neuwelt EA, Saloner DA, Young WL.

Transl Stroke Res. 2012 Jul;3(Suppl 1):166-73. doi: 10.1007/s12975-012-0172-y.

40.

Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors.

Khush KK, Pawlikowska L, Menza RL, Goldstein BA, Hayden V, Nguyen J, Kim H, Poon A, Sapru A, Matthay MA, Kwok PY, Young WL, Baxter-Lowe LA, Zaroff JG.

Am J Transplant. 2012 Dec;12(12):3377-86. doi: 10.1111/j.1600-6143.2012.04266.x. Epub 2012 Sep 20.

41.

Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations.

Nishida T, Faughnan ME, Krings T, Chakinala M, Gossage JR, Young WL, Kim H, Pourmohamad T, Henderson KJ, Schrum SD, James M, Quinnine N, Bharatha A, Terbrugge KG, White RI Jr.

Am J Med Genet A. 2012 Nov;158A(11):2829-34. doi: 10.1002/ajmg.a.35622. Epub 2012 Sep 18.

42.

Cerebellar arteriovenous malformations: anatomic subtypes, surgical results, and increased predictive accuracy of the supplementary grading system.

Rodríguez-Hernández A, Kim H, Pourmohamad T, Young WL, Lawton MT; University of California, San Francisco Arteriovenous Malformation Study Project.

Neurosurgery. 2012 Dec;71(6):1111-24. doi: 10.1227/NEU.0b013e318271c081.

43.

Anesthesia for endovascular neurosurgery and interventional neuroradiology.

Lee CZ, Young WL.

Anesthesiol Clin. 2012 Jun;30(2):127-47. doi: 10.1016/j.anclin.2012.05.009. Epub 2012 Jul 13. Review.

PMID:
22901603
44.

Elderly age as a prognostic marker of 1-year poor outcome for subarachnoid hemorrhage patients through its interaction with admission hydrocephalus.

Degos V, Gourraud PA, Tursis VT, Whelan R, Colonne C, Korinek AM, Clarençon F, Boch AL, Nouet A, Young WL, Apfel CC, Puybasset L.

Anesthesiology. 2012 Dec;117(6):1289-99. doi: 10.1097/ALN.0b013e318267395b.

PMID:
22854979
45.

Evaluating performance of the spetzler-martin supplemented model in selecting patients with brain arteriovenous malformation for surgery.

Kim H, Pourmohamad T, Westbroek EM, McCulloch CE, Lawton MT, Young WL.

Stroke. 2012 Sep;43(9):2497-9. doi: 10.1161/STROKEAHA.112.661942. Epub 2012 Jul 19.

46.

Brain-derived neurotrophic factor Val66Met polymorphism predicts worse functional outcome after surgery in patients with unruptured brain arteriovenous malformation.

Westbroek EM, Pawlikowska L, Lawton MT, McCulloch CE, Young WL, Kim H.

Stroke. 2012 Aug;43(8):2255-7. doi: 10.1161/STROKEAHA.112.663096. Epub 2012 Jul 5.

47.

Pediatric intracranial nongalenic pial arteriovenous fistulas: clinical features, angioarchitecture, and outcomes.

Hetts SW, Keenan K, Fullerton HJ, Young WL, English JD, Gupta N, Dowd CF, Higashida RT, Lawton MT, Halbach VV.

AJNR Am J Neuroradiol. 2012 Oct;33(9):1710-9. doi: 10.3174/ajnr.A3194. Epub 2012 Jul 5.

48.

Hull down on the horizon: A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial.

Mohr JP, Moskowitz AJ, Parides M, Stapf C, Young WL.

Stroke. 2012 Jul;43(7):1744-5. doi: 10.1161/STROKEAHA.112.653584. Epub 2012 Jun 5. No abstract available.

PMID:
22669405
49.

Perlecan domain V is upregulated in human brain arteriovenous malformation and could mediate the vascular endothelial growth factor effect in lesional tissue.

Kahle MP, Lee B, Pourmohamad T, Cunningham A, Su H, Kim H, Chen Y, McCulloch CE, Barbaro NM, Lawton MT, Young WL, Bix GJ.

Neuroreport. 2012 Jul 11;23(10):627-30. doi: 10.1097/WNR.0b013e3283554c5c.

50.

Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients.

Englot DJ, Young WL, Han SJ, McCulloch CE, Chang EF, Lawton MT.

Neurosurgery. 2012 Sep;71(3):572-80; discussion 580. doi: 10.1227/NEU.0b013e31825ea3ba.

Supplemental Content

Loading ...
Support Center